日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Quemliclustat联合化疗(加或不加zimberelimab)治疗转移性胰腺腺癌:一项随机1期试验

Wainberg, Zev A; Manji, Gulam A; Bahary, Nathan; Ulahannan, Susanna V; Pant, Shubham; Spigel, David R; Uboha, Nataliya V; Oberstein, Paul E; Saeed, Anwaar; Beagle, Brandon; Kim, Ji Yun; Wang, Ning; Weeder, Ben; Shitole, Shravani; Mrouj, Karim; Scott, Jennifer R; Ensign, Lisa G; DiRenzo, Daniel M; Walters, Matthew J; Wu, Wilson; Kaplan, Angelo; Cho, Soonweng; Kabbarah, Omar; O'Reilly, Eileen M

Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial

新辅助改良FOLFIRINOX方案联合纳武利尤单抗治疗临界可切除胰腺导管腺癌:一项I期试点试验

Wainberg, Zev A; Link, Jason M; Premji, Alykhan; Zheng, Serena; Srienc, Michael; Hammons, McKensie; Kim, Shineui E; Li, Luyi; Liu, Zeyu; Tsvetkova, Olga; Abt, Evan R; Rosen, Lee; Kim, Stephen; King, Jonathan; Hines, O Joe; Girgis, Mark; Sadeghi, Saeed; Olevsky, Olga; Wong, Deborah; Yonemoto, Lisa; Siney, Ann Marie; Kelly, Kim; Kivork, Christine; Tseng, Chi-Hong; Radu, Caius G; Dawson, David W; Donahue, Timothy R

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

一项针对未经治疗的转移性胰腺腺癌患者的吉西他滨/白蛋白紫杉醇联合纳武利尤单抗/伊匹木单抗或羟氯喹/伊匹木单抗的1期临床试验的临床和转化结果

O'Reilly, Eileen M; Cabanski, Christopher R; Lyman, Jaclyn P; Wainberg, Zev A; Fisher, George A; Wolff, Robert A; Ko, Andrew H; O'Hara, Mark H; Spencer, Christine N; Yu, Jia Xin; Da Silva, Diane M; Padrón, Lacey J; Arnott, Jamie; Fairchild, Justin; Moore, Jonni S; Peng, Brandon; Hoos, William A; O'Donnell-Tormey, Jill; Boffo, Silvia; Dugan, Ute; Kimmelman, Alec C; Amaravadi, Ravi K; Vonderheide, Robert H

NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial

在老年初治转移性胰腺癌患者中,NALIRIFOX 与白蛋白结合型紫杉醇联合吉西他滨的疗效比较:一项关键性 NAPOLI 3 试验的亚组分析

Macarulla, T; Cid, R Pazo; Womack, M S; Gracian, A Cubillo; Zervoudakis, A; Hatoum, H; Chung, V; Patel, A; Paulson, A S; Pant, S; O'Reilly, E M; Hubner, R A; Van Cutsem, E; Bekaii-Saab, T; Zhang, L; Li, J; Chen, H; Maxwell, F; Wainberg, Z A; Melisi, D

Neoadjuvant stereotactic body vs conventionally fractionated radiation therapy for borderline resectable and locally advanced pancreatic cancer: a propensity score-matched analysis

新辅助立体定向体部治疗与常规分割放射治疗治疗临界可切除和局部晚期胰腺癌:倾向评分匹配分析

Shimizu, Takayuki; Zheng, Serena; Maeda, Shimpei; Link, Jason; Deranteriassian, Aletta; Premji, Alykhan; King, Johathan; Girgis, Mark; Hines, Oscar Joe; Wainberg, Zev; Raldow, Ann; He, Jin; Burns, William; Narang, Amol; Qadan, Motaz; Castillo, Carlos Fernandez-Del; Lillemoe, Keith D; Wo, Jennifer; Hong, Theodore; Donahue, Timothy R

Identifying Community-Sourced Implementation Strategies for Delivering a Task-Shared Mental Health Intervention for Fathers in Kenya

确定肯尼亚父亲心理健康干预项目社区主导的实施策略,该项目采用任务分担的方式开展

Giusto, Ali; Jaguga, Florence; Greenlee, Michaela; Triplett, Noah; Rono, Wilter; Rukh-E-Qamar, Hani; Korir, Mercy; Aburi, Dan; Wainberg, Milton

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results

靶向淋巴结的mKRAS特异性两亲性疫苗治疗胰腺癌和结直肠癌:AMPLIFY-201 I期试验最终结果

Zev A Wainberg ,Colin D Weekes ,Muhammad Furqan ,Pashtoon M Kasi ,Craig E Devoe ,Alexis D Leal ,Vincent Chung ,James R Perry ,Thian Kheoh ,Lisa K McNeil ,Esther Welkowsky ,Peter C DeMuth ,Christopher M Haqq ,Shubham Pant # ,Eileen M O'Reilly #

Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial

Domvanalimab 和 zimberelimab 治疗晚期胃癌、胃食管交界处癌或食管癌:一项 II 期试验

Janjigian, Yelena Y; Oh, Do-Youn; Pelster, Meredith; Wainberg, Zev A; Prusty, Subhransu; Nelson, Sandahl; DuPage, Amy; Thompson, Amy; Koralek, Daniel O; Sison, Edward Allan R; Rha, Sun Young

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

乐伐替尼联合帕博利珠单抗和化疗对比单纯化疗治疗晚期转移性胃食管腺癌:III期随机LEAP-015研究

Shitara, Kohei; Lorenzen, Sylvie; Li, Jin; Bai, Yuxian; Fernández, Manuel González; Aguilar, Mynor; Shoji, Hirokazu; Reyes-Cosmelli, Felipe; Peña, Yovany Rodriguez; Corrales, Luis; Wyrwicz, Lucjan; Eyzaguirre, Daniel Acosta; Pan, Yueyin; Ryu, Min-Hee; Cohen, Deirdre J; Wainberg, Zev A; Ku, Geoffrey; Tabernero, Josep; Van Cutsem, Eric; Qin, Shu-Kui; Oh, Do-Youn; Xu, Jianming; Liang, Li Wen; Bordia, Sonal; Bhagia, Pooja; Rha, Sun Young

DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish

DKN-01联合替雷利珠单抗和化疗作为晚期胃癌或胃食管交界处腺癌的一线治疗:DisTinGuish

Klempner, Samuel J; Sonbol, Mohamad Bassam; Wainberg, Zev A; Uronis, Hope Elizabeth; Chiu, Vi K; Scott, Aaron James; Iqbal, Syma; Tejani, Mohamedtaki Abdulaziz; Chung, Vincent; Stilian, Melissa C; Thoma, Mathis; Zhang, Ying; Kagey, Michael H; Baum, Jason; Sirard, Cynthia A; Altura, Rachel A; Ajani, Jaffer A